Comparison between Indian version and Bangladesh version of Olaparib

The Indian version and Bangladeshi version of Olaparib fall into the category of generic drug production, but as far as we know, no Indian pharmaceutical factory has produced its generic version. The pharmaceutical ingredients of generic olaparib are basically the same as those of the original drug, but the manufacturers are different, and there may be differences in the specifications, prices, packaging, etc. of the drugs produced. Lynparzais a type of drug called aPARP (polymerase chain reaction) inhibitor. It belongs to a class of targeted cancer drugs used to treat certain types of ovarian, breast, prostate and pancreatic cancer. The price of each box of 150mg*120 tablets produced by Bangladesh Yaopin International Pharmaceutical Factory may be around RMB 4,000 (the price may fluctuate due to the exchange rate).